These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is there an indication for embolic protection in renal artery intervention? Holden A Tech Vasc Interv Radiol; 2011 Jun; 14(2):95-100. PubMed ID: 21550512 [TBL] [Abstract][Full Text] [Related]
3. The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Gray WA; Yadav JS; Verta P; Scicli A; Fairman R; Wholey M; Hopkins LN; Atkinson R; Raabe R; Barnwell S; Green R; Catheter Cardiovasc Interv; 2007 Dec; 70(7):1025-33. PubMed ID: 18044758 [TBL] [Abstract][Full Text] [Related]
4. Current debate on the role of embolic protection devices. Bornak A; Milner R Vasc Endovascular Surg; 2012 Aug; 46(6):441-6. PubMed ID: 22723261 [TBL] [Abstract][Full Text] [Related]
5. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries. Quan VH; Huynh R; Seifert PA; Kuchela A; Chen WH; Sütsch G; Eisenhauer AC; Rogers C Am J Cardiol; 2005 Jun; 95(12):1415-9. PubMed ID: 15950562 [TBL] [Abstract][Full Text] [Related]
6. A role for embolic protection in the management of acute limb ischemia. Taleb M; Burket MW; Cooper CJ Tech Vasc Interv Radiol; 2011 Jun; 14(2):75-9. PubMed ID: 21550509 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Baim DS; Wahr D; George B; Leon MB; Greenberg J; Cutlip DE; Kaya U; Popma JJ; Ho KK; Kuntz RE; Circulation; 2002 Mar; 105(11):1285-90. PubMed ID: 11901037 [TBL] [Abstract][Full Text] [Related]
8. Advantages and limitations of robotic endovacular catheters for carotid artery stenting. Riga CV; Rolls A; Rippel R; Shah C; Hamady M; Bicknell C; Cheshire N J Cardiovasc Surg (Torino); 2012 Dec; 53(6):747-53. PubMed ID: 23207557 [TBL] [Abstract][Full Text] [Related]
9. Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE database. Khalid N; Javed H; Rogers T; Hashim H; Shlofmitz E; Chen Y; Khan JM; Musallam A; Torguson R; Bernardo NL; Waksman R Catheter Cardiovasc Interv; 2019 Jul; 94(1):157-164. PubMed ID: 30985082 [TBL] [Abstract][Full Text] [Related]
10. Interventional therapy for carotid artery disease using angioplasty and stenting with embolic protection. Loftus ML; Schumacher HC; Meyers PM Minerva Cardioangiol; 2006 Oct; 54(5):679-85. PubMed ID: 17019402 [TBL] [Abstract][Full Text] [Related]
11. Feasibility, safety, and early outcomes of direct carotid artery stent implantation with use of the FilterWire EZ Embolic Protection System. Veselka J; Cerná D; Zimolová P; Martinkovicová L; Fiedler J; Hájek P; Malý M; Zemánek D; Duchonová R Catheter Cardiovasc Interv; 2009 May; 73(6):733-8. PubMed ID: 19198010 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of randomized trials comparing anti-embolic devices with standard PCI for improving myocardial reperfusion in patients with acute myocardial infarction. Kunadian B; Dunning J; Vijayalakshmi K; Thornley AR; de Belder MA Catheter Cardiovasc Interv; 2007 Mar; 69(4):488-96. PubMed ID: 17286249 [TBL] [Abstract][Full Text] [Related]
13. The impact of embolic protection device and stent design on the outcome of CAS. Bosiers M; Deloose K; Verbist J; Peeters P Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):272-9. PubMed ID: 18930936 [TBL] [Abstract][Full Text] [Related]
14. Use of a Dual-Filter Embolic Protection Device for Brachiocephalic Artery Stenting. Sadiq A; Goldsweig AM; O'Leary EL Ann Vasc Surg; 2020 May; 65():282.e13-282.e15. PubMed ID: 31676379 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Clair DG; Hopkins LN; Mehta M; Kasirajan K; Schermerhorn M; Schönholz C; Kwolek CJ; Eskandari MK; Powell RJ; Ansel GM; Catheter Cardiovasc Interv; 2011 Feb; 77(3):420-9. PubMed ID: 20853365 [TBL] [Abstract][Full Text] [Related]
18. Carotid stenting with a new system for distal embolic protection and stenting in high-risk patients: the carotid revascularization with ev3 arterial technology evolution (CREATE) feasibility trial. Safian RD; Bacharach JM; Ansel GM; Criado FJ Catheter Cardiovasc Interv; 2004 Sep; 63(1):1-6. PubMed ID: 15343559 [TBL] [Abstract][Full Text] [Related]